The Serotonin-Immune Axis in Preeclampsia

Area of Science:

• Reproductive immunology
• Maternal-fetal medicine
• Neuroendocrinology

Background:

• Preeclampsia is a severe pregnancy complication with significant risks.
• Current treatment is limited to delivery, highlighting the need for novel therapies.
• Serotonin dysregulation is implicated in preeclampsia's vascular and platelet dysfunction.

Purpose of the Study:

• To review literature on immune mechanisms linking hyperserotonemia to preeclampsia.
• To explore how hyperserotonemia drives pro-inflammation in preeclampsia.
• To identify potential therapeutic targets for preeclampsia.

Main Methods:

• Literature review of immune mechanisms in preeclampsia.
• Analysis of serotonin's role in immune cell function and cytokine production.
• Examination of kynurenine pathway alterations.

Main Results:

• Increased serotonin (hyperserotonemia) is observed in maternal and placental domains.
• Pro-inflammation in preeclampsia may be driven by hyperserotonemia.
• Key mechanisms include altered immune cells, kynurenine metabolism, and cytokine profiles.

Conclusions:

• Hyperserotonemia contributes to preeclampsia's pro-inflammatory state.
• Immune mechanisms involving metabolic, cellular, and cytokine pathways are critical.
• Targeting these immune pathways presents a promising therapeutic strategy for preeclampsia.